Aims
In vivo studies with model organisms are critical for uncovering the complex interactions between genes, cells, organisms and their environment. As a Nature Research journal, LabAnimal is dedicated to publishing the latest innovations in in vivo science & technology. In addition, LabAnimal also strives to provide the in vivo community with expert opinions on a range of topics through reviews and perspectives, as well as important news in industry, policy and regulatory matters impacting basic and preclinical research.
LabAnimal encourages submissions of innovative methods and techniques that improve and expand the use of model organisms in the lab, and research that deepens our basic understanding of model organisms and the opportunities/challenges for modeling human health and disease. 
For primary research articles, to ensure complete methodological reporting authors are required to submit the ARRIVE guidelines checklist as supplemental material along with their manuscripts. For any areas in the ARRIVE guidelines that do not apply to their manuscript, authors should mark N/A.
Data policy: the goal of LabAnimal is to provide the in vivo community with knowledge critical for developing and improving the use of model organisms in the laboratory, and we support a transparent approach to publishing. Authors of submitted primary research manuscripts are required to provide numerical data sets used for analysis and figures in a readily accessible form via supplementary material, public repository, or provide a statement of data availability. Authors of published papers are also required to make any code, materials or protocols associated with the paper promptly available to readers without undue qualifications.
Scope
The journal’s broad scope covers invertebrate and vertebrate models and a wide breadth of in vivo methods and topics including, but not limited to:
Phenotyping
Genetics
Behavior
Development
Microbiome
Imaging
Bioinformatics
High-throughput methods
Omics methods and data (phenomics, genomics, metabolomics)
Novel platforms for physiology and behavior
Chimeras and applied stem cell technologies
Disease models
Stress and pain
Experimental design
Preclinical studies
Vivarium innovations

Article
Protocol
Review
Perspective
Comment
Correspondence
Matters Arising
News and Technology

Chief Editor: Alexandra Le Bras
Alexandra did her PhD at the Institute of Biology in Lille, France, where she studied the transcriptional and epigenetic mechanisms regulating endothelial gene expression. She then conducted postdoctoral research, investigating vascular development in stem cell and mouse models (Harvard Medical School, USA) and working on gene and cell therapy approaches for cardiovascular disease (King’s College London, UK). Before joining LabAnimal in February 2019, she was Locum Associate Editor at Nature Reviews Cardiology for a year.
alexandra.lebras@nature.com
Associate Editor: Ellen Neff
Ellen joined LabAnimal in the summer of 2016. Before starting in editorial, she was a coordinator for a NASA Earth Science metadata project, focused on facilitating accessible research that is comprehensible to a broad audience. She studied biology with minors in chemistry and classics at the University of Pittsburgh and completed her graduate degree in marine biology at Northeastern University. Although her invertebrate subjects were outside the purview of IACUCs, she has experience in whole organism biology and the science of indirect effects and interactions. 
Editorial Advisory Panel
In addition to our editorial team, LabAnimal has an editorial advisory panel with experts from academia and industry in fields covering in vivo science & technology.
Leanne Alworth, DVM, MS, DACLAM
Assistant Director/Attending Veterinarian, University of Georgia, Athens, GA
Jeffrey Everitt, DVM
Department of Pathology, Duke University, Durham, NC
Charmaine Foltz, DVM, DACLAM
Director, Division of Veterinary Resources, NIH, Bethesda, MD
Paul Houghton
CEO, Biologist, Primate Products, Redwood City, CA
Robert F. Hoyt, Jr., DVM, MS, DACLAM
Animal Program Director, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, MD
Mary Lou James, BA, RLATG
Consultant, Regulatory Compliance, St. Louis, MO
Bruce W. Kennedy, MS, RLATG, CMAR, CPIA
IACUC Administrator, Office of Research, Chapman University, Orange, CA
Krishnan Kolappaswamy, DVM, PhD, DACLAM
Director and Attending Veterinarian, Research Model and Services, US, Envigo, Indianapolis, IN
Richard H. Latt, DVM, DACLAM
President, Mispro Biotech Services Inc., Montreal, Quebec, Canada
John A. Maher, MS, MBA, CMAR, RLATG
Associate Director, Comparative Medicine, Pfizer, Pearl River, NY
Jörg Mayer, Dr.med.vet., MSc, MRCVS, DABVP (ECM)
Associate Professor of Zoological Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA
Jo Ellen Sherow, BS, LATG
Director, Research Compliance, Ohio University, Athens, OH
Jerald Silverman, DVM, DACLAM
Director Emeritus, Department of Animal Medicine, and Professor Emeritus, Department of Pathology, University of Massachusetts Medical School, Worcester, MA
Michael K. Stoskopf, DVM, PhD, DACZM
Professor and Director of Environmental Medicine Consortium, College of Veterinary Medicine, North Carolina State University, Raleigh, NC
Robert H. Weichbrod, PhD, MBA, RLATG
Animal Program Administrator, National Eye Institute, NIH, Bethesda, MD
Axel Wolff, MS, DVM
Director, Division of Compliance Oversight, OLAW, NIH, Bethesda, MD